Second Sight Medical Products (NASDAQ: EYES) has seen its share price surge on Friday after the US Food and Drug Administration (FDA) approved the Argus 2s Retinal Prosthesis System.
Argus 2s is a redesigned set of external hardware initially for use combined with previously implanted Argos II systems for the treatment of retinitis pigmentosa.
The developer and marketer of implantable visual prosthetics expect the Argus 2s will be adapted to be the external system for the next generation Orion Visual Cortical Processing System, which is currently under development.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“In addition to ergonomic improvements, the Argus 2s system offers significantly more processing power, potentially allowing for improved video processing,” Second Sight said.
A decision on when to begin production of the hardware is pending the completion of Second Sight’s planned business combination with Pixium Vision, which is currently in progress.
“We are very pleased to have received this approval, as it presents an opportunity to offer external hardware that we believe enhance comfort and aesthetics compared with the legacy Argus II system,” commented Matthew Pfeffer, acting CEO of Second Sight.
The company’s shares are trading 140% higher at $3.44.